Precision AQ
Provides commercialization and market access services for pharmaceutical companies.
Company facts
- Founded
- 2012
- Employees
- 1,200
- Headquarters
- United States
- CEO
- Margaret Keegan
- Type
- Private
- Funding
- Private Equity · $532M · 2020
- Subsidiaries
- Across Health, Makara Health
About
At Precision AQ, we understand that our customers face significant barriers in accessing life-changing medicines, which is why we strive to empower access through innovative solutions. Our approach uniquely fuses evidence and empathy, ensuring that every aspect of our work is directed towards connecting patients with the treatments they need. With over 1,200 experts in our team, we provide comprehensive services that span the commercialization journey across the pharmaceutical and biotech sectors. We specialize in a variety of areas, including health economics and outcomes research (HEOR), market access, medical communications, and investor relations. Our goal is to enhance the journey from drug development to patient delivery, helping our clients navigate the complexities of healthcare systems globally. Whether it's through the development of real-world evidence to support payer negotiations, crafting targeted marketing strategies, or streamlining investor communications, Precision AQ is dedicated to making healthcare more accessible and equitable for all. By combining our data-driven insights with compassionate outreach, we aim to truly transform the healthcare landscape.